{"title":"Vaccine-related environments and patient preferences in Japanese patients with autoimmune rheumatic diseases.","authors":"Kenji Oku, Hidehiro Yamada, Tatsuyoshi Ikenoue, Masashi Akizuki, Hiroyuki Hagiyama, Haruko Ideguchi, Atsushi Ihata, Takuya Kakutani, Kimito Kawahata, Toshihiro Matsui, Junichi Obata, Shigeru Ohno, Shinji Sato, Naoki Sawa, Akiko Suda, Hiroaki Taguchi, Mitsuhiro Takeno, Atsuhisa Ueda, Masaomi Yamasaki, Kunihiro Yamaoka","doi":"10.1093/mr/roaf061","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate vaccination rates and identify factors associated with vaccine uptake among patients with autoimmune inflammatory rheumatic diseases (AIRD) in Kanagawa Prefecture, Japan.</p><p><strong>Methods: </strong>An anonymous survey was conducted between January and May 2023 using Google Forms™. Adult AIRD patients and rheumatologists were asked about demographics, disease characteristics, vaccination status, and attitudes towards vaccination. Logistic regression and Random Forest analyses were used to identify factors influencing vaccination rates.</p><p><strong>Results: </strong>A total of 1637 AIRD patients responded. Vaccination rates were as follows: herpes zoster (HZ) 8.8%, influenza 86.7%, pneumococcus 29.7%, HPV 4.3%, HBV 8.7%, and SARS-CoV-2 92.2%. Physician recommendations were significantly associated with higher vaccination rates. Although knowledge of vaccine efficacy correlated with increased uptake, it did not fully alleviate vaccine hesitancy. Major barriers included concerns about adverse effects and lack of sufficient information.</p><p><strong>Conclusions: </strong>Physician recommendations and providing comprehensive vaccine information are essential for improving vaccination rates among AIRD patients. Addressing concerns about vaccine safety and efficacy through targeted educational interventions and communication strategies is crucial to enhancing vaccine uptake.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mr/roaf061","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To evaluate vaccination rates and identify factors associated with vaccine uptake among patients with autoimmune inflammatory rheumatic diseases (AIRD) in Kanagawa Prefecture, Japan.
Methods: An anonymous survey was conducted between January and May 2023 using Google Forms™. Adult AIRD patients and rheumatologists were asked about demographics, disease characteristics, vaccination status, and attitudes towards vaccination. Logistic regression and Random Forest analyses were used to identify factors influencing vaccination rates.
Results: A total of 1637 AIRD patients responded. Vaccination rates were as follows: herpes zoster (HZ) 8.8%, influenza 86.7%, pneumococcus 29.7%, HPV 4.3%, HBV 8.7%, and SARS-CoV-2 92.2%. Physician recommendations were significantly associated with higher vaccination rates. Although knowledge of vaccine efficacy correlated with increased uptake, it did not fully alleviate vaccine hesitancy. Major barriers included concerns about adverse effects and lack of sufficient information.
Conclusions: Physician recommendations and providing comprehensive vaccine information are essential for improving vaccination rates among AIRD patients. Addressing concerns about vaccine safety and efficacy through targeted educational interventions and communication strategies is crucial to enhancing vaccine uptake.
期刊介绍:
Modern Rheumatology publishes original papers in English on research pertinent to rheumatology and associated areas such as pathology, physiology, clinical immunology, microbiology, biochemistry, experimental animal models, pharmacology, and orthopedic surgery.
Occasional reviews of topics which may be of wide interest to the readership will be accepted. In addition, concise papers of special scientific importance that represent definitive and original studies will be considered.
Modern Rheumatology is currently indexed in Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, PubMed/Medline, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, EBSCO, CSA, Academic OneFile, Current Abstracts, Elsevier Biobase, Gale, Health Reference Center Academic, OCLC, SCImago, Summon by Serial Solutions